Séminaires virtuels du CHAPITRE EMBS/CASS de Québec
Mesure de SpO2 et au-delà: importance de l'oxymétrie dans le système de santé actuel en pleine évolution
François LELLOUCHE, MD, PhD, Institut universitaire de cardiologie et de pneumologie de Québec et professeur au Département de médecine de l'Université Laval
Vendredi le 3 décembre 2021 à 10h00, en direct sur Zoom / Friday December 3, 2021 at 10 am on Zoom :
https://us02web.zoom.us/j/88963498537?pwd=b1lxUGpFRTRtNlVRUkFVZnc2U2wrUT09
Résumé : La mesure de l'oxymétrie pulsée ou SpO2 (5ème signe vital) représente un enjeu majeur pour le système de santé. Les questions reliées à l'oxymétrie vont au-delà de la fiabilité de la mesure de la SpO2 (question non encore résolue) et des nombreuses valeurs dérivées qui peuvent être mesurées avec le même capteur. Nous discuterons des autres enjeux reliés aux nouvelles recommandations pour administrer et surveiller précisément l'oxygène, aux méthodes innovantes d'administrations de l'oxygénothérapie et autres stratégies de prise en charge des patients sous oxygène en ambulatoire.
François LELLOUCHE, MD, PhD obtained the MD degree in internal medicine in 2001 and critical care medicine in 2004 from the Pierre et Marie Curie University (Paris VI) and the PhD degree in Science and Engineering: Materials - Modeling - Environment, University of Paris XII, with Pr Laurent Brochard as supervisor. He was an INSERM – CIHR Postdoctoral Fellow at the Saint-Michael hospital laboratory (Pr Sinderby and Arthur Slutsky). He is currently critical care physician at the Quebec Heart and Lung University Institute and Associate Professor at the Department of medicine at Laval University. His research interests include humidification of gas during mechanical ventilation, noninvasive mechanical ventilation, high flow oxygen therapy and new modes of mechanical ventilation, focusing on automated modes of respiratory support and closed-loop oxygen supplementation. He conducts at the research center of the Quebec Heart and Lung Institute bench studies, physiological studies focusing on breathing physiology and clinical trials to evaluate the clinical impact based on preliminary studies. His laboratory develops several innovative devices in the field of respiratory and oxygen support, including the FreeO2 device, a new breakthrough closed loop device that titrates oxygen flow based on patient’ needs. He co-founded with Pr Erwan L’Her the Oxynov company that manufactures and commercializes the FreeO2 device in Europe, Asia and Canada. He developed the “VentilO” application to promote lung protective ventilation and explain the relations between tidal volume, respiratory rate and dead space. He is currently PI of several studies focusing on COVID-19 management including a CIHR funded multicentric study on automated oxygen titration to reduce healthcare workers interventions and a pilot study on new COVID treatments.
Date and Time
Location
Hosts
Registration
- Date: 03 Dec 2021
- Time: 10:00 AM to 11:00 AM
- All times are (GMT-05:00) Canada/Eastern
-
Add Event to Calendar
Speakers
Dr François Lellouche of Professor, Institut universitaire de cardiologie et de pneumologie de Québec et professeur au Département de médecine de l'Université Laval
Mesure de SpO2 et au-delà: importance de l'oxymétrie dans le système de santé actuel en pleine évolution
La mesure de l'oxymétrie pulsée ou SpO2 (5ème signe vital) représente un enjeu majeur pour le système de santé. Les questions reliées à l'oxymétrie vont au-delà de la fiabilité de la mesure de la SpO2 (question non encore résolue) et des nombreuses valeurs dérivées qui peuvent être mesurées avec le même capteur. Nous discuterons des autres enjeux reliés aux nouvelles recommandations pour administrer et surveiller précisément l'oxygène, aux méthodes innovantes d'administrations de l'oxygénothérapie et autres stratégies de prise en charge des patients sous oxygène en ambulatoire.
Biography:
François LELLOUCHE, MD, PhD obtained the MD degree in internal medicine in 2001 and critical care medicine in 2004 from the Pierre et Marie Curie University (Paris VI) and the PhD degree in Science and Engineering: Materials - Modeling - Environment, University of Paris XII, with Pr Laurent Brochard as supervisor. He was an INSERM – CIHR Postdoctoral Fellow at the Saint-Michael hospital laboratory (Pr Sinderby and Arthur Slutsky). He is currently critical care physician at the Quebec Heart and Lung University Institute and Associate Professor at the Department of medicine at Laval University. His research interests include humidification of gas during mechanical ventilation, noninvasive mechanical ventilation, high flow oxygen therapy and new modes of mechanical ventilation, focusing on automated modes of respiratory support and closed-loop oxygen supplementation. He conducts at the research center of the Quebec Heart and Lung Institute bench studies, physiological studies focusing on breathing physiology and clinical trials to evaluate the clinical impact based on preliminary studies. His laboratory develops several innovative devices in the field of respiratory and oxygen support, including the FreeO2device, a new breakthrough closed loop device that titrates oxygen flow based on patient’ needs. He co-founded with Pr Erwan L’Her the Oxynov company that manufactures and commercializes the FreeO2device in Europe, Asia and Canada. He developed the “VentilO” application to promote lung protective ventilation and explain the relations between tidal volume, respiratory rate and dead space. He is currently PI of several studies focusing on COVID-19 management including a CIHR funded multicentric study on automated oxygen titration to reduce healthcare workers interventions and a pilot study on new COVID treatments.